Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 USD | +1.79% | +12.87% | -45.73% |
May. 28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
May. 14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 13.68M | Sales 2025 * | 21.9M | Capitalization | 4.81M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 3M | EV / Sales 2024 * | 0.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.22 x |
P/E ratio 2024 * |
-7
x | P/E ratio 2025 * |
5.6
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.09% |
Latest transcript on Evoke Pharma, Inc.
1 day | +2.75% | ||
1 week | +17.89% | ||
Current month | +17.89% | ||
1 month | +17.89% | ||
3 months | -20.00% | ||
6 months | -53.72% | ||
Current year | -46.68% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 0.57 | +1.79% | 9 916 |
24-06-07 | 0.56 | +2.75% | 63,002 |
24-06-06 | 0.545 | -0.73% | 19,730 |
24-06-05 | 0.549 | +9.80% | 8,546 |
24-06-04 | 0.5 | -0.99% | 12,612 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.68% | 4.81M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.82% | 248B | |
-1.31% | 219B | |
+11.04% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- EVOK Stock